BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu L, Zhou J, Huang S, Huang Y, LE Y, Jiang D, Wang F, Yang X, Xu W, Huang X, Dong C, Zhang L, Ye M, Lian J, Duan S. An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A(2) and coronary heart disease. Exp Ther Med 2013;5:742-50. [PMID: 23404648 DOI: 10.3892/etm.2013.911] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Jiang D, Wang Y, Shen Y, Xu Y, Zhu H, Wang J, Wang H, Duan S. Estrogen and promoter methylation in the regulation of PLA2G7 transcription. Gene 2016;591:262-7. [PMID: 27450918 DOI: 10.1016/j.gene.2016.07.048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Aung LH, Yin RX, Wu DF, Wang W, Liu CW, Pan SL. Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia. J Cell Mol Med 2014;18:1417-28. [PMID: 24780069 DOI: 10.1111/jcmm.12291] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
3 Xu X, Li Y, Huang Y, Ye H, Han L, Ji H, Chen X, Wu N, Jiang D, Xu L, Dai D, Duan S, Chen X. Impact of gender and age on the association of the BUD13-ZNF259 rs964184 polymorphism with coronary heart disease. Anatol J Cardiol 2018;19:42-9. [PMID: 29339699 DOI: 10.14744/AnatolJCardiol.2017.8002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Veturi Y, Lucas A, Bradford Y, Hui D, Dudek S, Theusch E, Verma A, Miller JE, Kullo I, Hakonarson H, Sleiman P, Schaid D, Stein CM, Edwards DRV, Feng Q, Wei WQ, Medina MW, Krauss RM, Hoffmann TJ, Risch N, Voight BF, Rader DJ, Ritchie MD. A unified framework identifies new links between plasma lipids and diseases from electronic medical records across large-scale cohorts. Nat Genet 2021;53:972-81. [PMID: 34140684 DOI: 10.1038/s41588-021-00879-y] [Reference Citation Analysis]
5 Paul MR, Levitt NP, Moore DE, Watson PM, Wilson RC, Denlinger CE, Watson DK, Anderson PE. Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA. BMC Genomics 2016;17:263. [PMID: 27029813 DOI: 10.1186/s12864-016-2542-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ye H, Zhou A, Hong Q, Chen X, Xin Y, Tang L, Dai D, Ji H, Xu M, Wang DW, Duan S. Association of seven thrombotic pathway gene CpG-SNPs with coronary heart disease. Biomed Pharmacother 2015;72:98-102. [PMID: 26054681 DOI: 10.1016/j.biopha.2015.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
7 Ye H, Zhou A, Hong Q, Tang L, Xu X, Xin Y, Jiang D, Dai D, Li Y, Wang DW, Duan S. Positive Association between APOA5 rs662799 Polymorphism and Coronary Heart Disease: A Case-Control Study and Meta-Analysis. PLoS One 2015;10:e0135683. [PMID: 26309253 DOI: 10.1371/journal.pone.0135683] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
8 Khan MI, Hariprasad G. Human Secretary Phospholipase A2 Mutations and Their Clinical Implications. J Inflamm Res 2020;13:551-61. [PMID: 32982370 DOI: 10.2147/JIR.S269557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Peng LL, Zhao YQ, Zhou ZY, Jin J, Zhao M, Chen XM, Chen LY, Cai YF, Li JL, Huang M. Associations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy. Acta Pharmacol Sin 2016;37:1442-8. [PMID: 27641736 DOI: 10.1038/aps.2016.90] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
10 Huang Y, Ye H, Hong Q, Xu X, Jiang D, Xu L, Dai D, Sun J, Gao X, Duan S. Association of CDKN2BAS polymorphism rs4977574 with coronary heart disease: a case-control study and a meta-analysis. Int J Mol Sci 2014;15:17478-92. [PMID: 25268619 DOI: 10.3390/ijms151017478] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
11 Prasad M, Lennon R, Barsness GW, Prasad A, Gulati R, Lerman LO, Lerman A. Chronic inhibition of lipoprotein-associated phospholipase A2 does not improve coronary endothelial function: A prospective, randomized-controlled trial. Int J Cardiol 2018;253:7-13. [PMID: 29306475 DOI: 10.1016/j.ijcard.2017.09.171] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Aung LH, Yin RX, Wu DF, Wang W, Wu JZ, Liu CW. Sex-specific association of the zinc finger protein 259 rs2075290 polymorphism and serum lipid levels. Int J Med Sci 2014;11:471-8. [PMID: 24688311 DOI: 10.7150/ijms.8489] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
13 Huang F, Wang K, Shen J. Lipoprotein-associated phospholipase A2: The story continues. Med Res Rev 2020;40:79-134. [PMID: 31140638 DOI: 10.1002/med.21597] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
14 Chen X, Chen X, Xu Y, Yang W, Wu N, Ye H, Yang JY, Hong Q, Xin Y, Yang MQ, Deng Y, Duan S. Association of six CpG-SNPs in the inflammation-related genes with coronary heart disease. Hum Genomics 2016;10 Suppl 2:21. [PMID: 27461004 DOI: 10.1186/s40246-016-0067-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
15 Varga TV, Sonestedt E, Shungin D, Koivula RW, Hallmans G, Escher SA, Barroso I, Nilsson P, Melander O, Orho-Melander M, Renström F, Franks PW. Genetic determinants of long-term changes in blood lipid concentrations: 10-year follow-up of the GLACIER study. PLoS Genet 2014;10:e1004388. [PMID: 24922540 DOI: 10.1371/journal.pgen.1004388] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
16 Hong M, Zhang M, Lu X. Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population. Mamm Genome 2015;26:191-9. [PMID: 25690150 DOI: 10.1007/s00335-015-9559-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Huang EW, Peng LY, Zheng JX, Wang D, Tan XH, Yang ZY, Li XM, Wu QP, Tang SB, Luo B, Quan L, Liu SP, Liu XS, Li ZH, Shi H, Lv GL, Zhao J, Liu C, Cheng JD. Investigation of associations between ten polymorphisms and the risk of coronary artery disease in Southern Han Chinese. J Hum Genet 2016;61:389-93. [PMID: 26740236 DOI: 10.1038/jhg.2015.158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
18 Chi Y, Shi C, Zhang X, Xi Y. Interaction between nonsynonymous polymorphisms in PLA2G7 gene and smoking on the risk of coronary heart disease in a Chinese population. J Thromb Thrombolysis 2018;46:125-30. [DOI: 10.1007/s11239-018-1671-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]